Advertisement

Topics

Ewopharma to commercialize Eisai drugs in Central Eastern Europe

06:48 EDT 23 Jun 2017 | thePharmaLetter

Ewopharma revealed yesterday that, as of April 1 this year, it has acquired the rights to commercialize…

Original Article: Ewopharma to commercialize Eisai drugs in Central Eastern Europe

NEXT ARTICLE

More From BioPortfolio on "Ewopharma to commercialize Eisai drugs in Central Eastern Europe"

Advertisement
Quick Search
Advertisement
Advertisement